Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/2005
04/21/2005US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders
04/21/2005US20050085494 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
04/21/2005US20050085491 Novel crystalline forms of valacyclovir hydrochloride
04/21/2005US20050085480 Water-soluble phenylpyridazine compounds and compositions containing the same
04/21/2005US20050085476 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants
04/21/2005US20050085448 Viricides against herpes virus; autoimmune disease; antitumor agents
04/21/2005US20050085416 Stabilized albumin, fatty acid complex; anticancer agents; bactericides
04/21/2005US20050085413 Dimeric pharmaceutical compounds and their use
04/21/2005US20050084947 Recombinant RSV virus expression systems and vaccines
04/21/2005US20050084897 DNA encoding human vanilloid receptor VR3
04/21/2005US20050084861 Methods of detecting modification of genetic material and monitoring processes thereof
04/21/2005US20050084845 Immunoglobulin specific to hepatitis c viral envelope protein for use as tool prevention and treatment of viral diseases
04/21/2005US20050084553 Composition containing moutan root bark extract as active ingredient
04/21/2005US20050084552 Pharmaceutical composition of chinese herbs for treating snuffle, headache and the use thereof
04/21/2005US20050084521 A non-aqueous adhesive layer on a side of the support and comprising an adhesive and a vaporizable antimicrobial agent; antimicrobial adhesive sheet has a moisture permeability of at least 1,000 g/m2*24 hrs; exerts the antimicrobial activity not only on an attached site but also in the space by the site
04/21/2005US20050084503 Continuous cell line for the production of vaccines
04/21/2005US20050084502 Equine herpesvirus vaccine
04/21/2005US20050084486 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
04/21/2005US20050084482 As an antiinflammatory agent for gastrointestinal inflammation involved with inflammatory bowel disease or irritable bowel syndrome
04/21/2005US20050084463 Antiinflammatory, antiarthritic agents, analgesics for pain caused by diabetic assoicated conditions, pneumoconiosis, angina, menstruation or cancer
04/21/2005CA2578473A1 Peptide nucleic acid conjugates and uses thereof
04/21/2005CA2541582A1 Indoles and azaindoles as antiviral agents
04/21/2005CA2539449A1 Pharmaceutical formulations of xanthogenates and inhibitors of viral nucleic acid replication (e.g. aciclovir)
04/21/2005CA2538106A1 Antimicrobial compositions comprising modified catechins and methods of use therein
04/21/2005CA2535982A1 Uses of interferons with altered spatial structure
04/20/2005EP1524263A1 prodrugs containing cycloalkene derivatives
04/20/2005EP1523998A2 Antimicrobial adhesive sheet and antimicrobial method using the same
04/20/2005EP1523997A1 A medical dressing comprising an antimicrobial silver compound
04/20/2005EP1523992A1 Vaccine formulation against Gumboro disease
04/20/2005EP1523990A1 Cellular vesicles denoted as 'exosomes', their preparation and use in the stimulation of an immune response
04/20/2005EP1523982A2 Plenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
04/20/2005EP1523887A2 Synergistic microbicidal combinations
04/20/2005EP1523582A2 Rapid, efiicient purification of hsv-specific t-lymphocytes and hsv antigens identified via same
04/20/2005EP1523556A1 Methods of treating conditions associated with an edg-1 receptor
04/20/2005EP1523489A2 Modified 2' and 3' -nucleoside produgs for treating flaviridae infections
04/20/2005EP1523488A1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
04/20/2005EP1523471A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments
04/20/2005EP1523470A1 Novel compounds as histone deacetylase inhibitors
04/20/2005EP1523332A1 Medicament for the treatment of diseases due to infection by neisseria meningitidis
04/20/2005EP1523331A2 Therapeutic tb vaccine
04/20/2005EP1523330A2 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells
04/20/2005EP1523328A2 Methods and compositions for inhibiting hiv replication
04/20/2005EP1523324A1 Treatment of serious infections and septic shock
04/20/2005EP1523320A1 Megasphaera elsdenii strain and its uses
04/20/2005EP1523310A2 Method to inhibit ischemia and reperfusion injury
04/20/2005EP1523239A1 Use of a composition and a cleaning tablet containing said composition for disinfecting purposes
04/20/2005EP1443921B1 Production of pure stereoisomers of tricyclo-[5.2.1.0(2.6)]-dec-9-yl-xanthate esters and their use as medicaments
04/20/2005EP1363626A4 Antifungal remedy formulation for external application
04/20/2005EP1357951B1 A medical dressing comprising an antimicrobial silver compound
04/20/2005EP1315807B1 Chimeric antisense oligonucleotides of arabinofuranose analogues and deoxyribose nucleotides
04/20/2005EP1292712A4 Means and methods for monitoring antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
04/20/2005EP1254161B1 Aerothricin analogs, their preparation and use
04/20/2005EP1254133B1 Indol-3-yl derivatives and their use as integrin inhibitors
04/20/2005EP1252158B1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
04/20/2005EP1210330B1 Antibacterial agents
04/20/2005EP1185649B1 The myostatin gene promoter and inhibition of activation thereof
04/20/2005EP1175435B1 Cephaibols, novel antiparasitics from acremonium tubakii, method for the production and the utilization thereof
04/20/2005EP1113817B1 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
04/20/2005EP1082093B8 Anti-germ attachment - composition
04/20/2005EP1059911B1 Formulations with an anti-viral effect
04/20/2005EP1049481B1 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
04/20/2005EP0989994B1 Streptogramines, their preparation and compositions containing them
04/20/2005EP0984947B1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
04/20/2005EP0954278B1 Pharmaceutical compositions containing kukui nut oil
04/20/2005EP0917471B1 Treatment and diagnosis of infections of gram positive cocci
04/20/2005EP0805859B1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses
04/20/2005EP0759995B1 Fusion glycoprotein from hcmv and hsv
04/20/2005EP0700430B1 Methods for selectively stimulating proliferation of t cells
04/20/2005CN1608133A Use of a double-stranded ribonucleic acid for treating an infection with a positivestrand rna-virus
04/20/2005CN1608067A Pyrrolopyrimidines as phosphodiesterase vii inhibitors
04/20/2005CN1608064A Novel compounds
04/20/2005CN1607960A Glycoprotein compositions
04/20/2005CN1607955A Methods and compositions for control of coccidiosis
04/20/2005CN1607949A Peptide arginals and methods for treating disseminated intravascular coagulation
04/20/2005CN1607948A Composition comprising paracetamol and a bitterness masking component
04/20/2005CN1607942A Pharmaceutical compositions in particulate form
04/20/2005CN1607941A Pharmaceutical compositions in particulate form
04/20/2005CN1607937A Injectable compositions for the controlled delivery of pharmacologically active compound
04/20/2005CN1607209A Poly thymosin-alpha 1, its composition, its preparation method and application
04/20/2005CN1607207A S protein of SARS virus, its vaccine and method for screening medicament using it
04/20/2005CN1607202A Antibiotic compound, pharmaceutical composition comprising the same and application thereof
04/20/2005CN1607010A Antimicrobial adhesive sheet and antimicrobial method using the same
04/20/2005CN1607004A Recombinant foot-and-mouth disease virus VP1 confluent protein vaccine
04/20/2005CN1607003A Auxiliary therapeutic agent for C type hepatitis
04/20/2005CN1607000A Chinese patent medicinal pill for curing syphilis and its preparation method
04/20/2005CN1606991A Externally applied medicine for treating beriberi and sweaty feet
04/20/2005CN1606983A Beta-L-2'deoxy-nucleosides for the treatment of hepatitis B
04/20/2005CN1606982A Fluconazole formulation
04/20/2005CN1606979A Effect of scutellarein as antifebrile, analgesic, antiphlogistic, antibiotic and antiviral agent
04/20/2005CN1197961C BHV-1 gene-deleted virus vaccine
04/20/2005CN1197877C AsLc-IFN fusion protein and its preparation
04/20/2005CN1197869C Aminoglycoside compound having antiviral activity and method for preparing same
04/20/2005CN1197867C Application of cinidium general coumarin as psoriasis treating medicine
04/20/2005CN1197860C FAB I inhibitors
04/20/2005CN1197849C 2, 3, 4, 5-tetrahydro-1H-[1, 4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
04/20/2005CN1197622C Emulsion-type lubricant for medical appliance and its application in medical rubber product
04/20/2005CN1197620C Use of immidazoquinolinamines as adjuvants in DNA vaccination
04/20/2005CN1197619C Biological therapy adjuvant originated from animal Chinese medicine
04/20/2005CN1197617C Fish serine proteinases and their pharmaceutical and cosmetic use
04/20/2005CN1197610C Chinese medicine preparation against cold